Form 4: Skye Bioscience Director Sells Shares
Insider Transaction (Form 4)
Andrew J. Schwab, a Director and 10% owner of Skye Bioscience, Inc., sold 33,892 shares of common stock on September 16, 2026 for $1.91 per share.
Summary
- Open-market sale: disposed of 32,607 Common Stock at $1.91 ($62,279) on September 16, 2026; holds 142,463 after (Indirect).
- Open-market sale: disposed of 1,285 Common Stock at $1.91 ($2,454) on September 16, 2026; holds 5,616 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $64,734 of stock on the open market.
Insider Transactions
Andrew J. Schwab — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Open-market sale | Common Stock | 32,607 | $2 | $62.3K | 142,463 |
| 2026-09-16 | Open-market sale | Common Stock | 1,285 | $2 | $2.5K | 5,616 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Open-market sale (32,607 shares) |
| 2026-09-16 | Open-market sale (1,285 shares) |
Keywords
insider transaction, Form 4, SKYE, Skye Bioscience, Inc., bearish, Andrew J. Schwab
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.